October 2012 FDA Recall Drug by Hospira Inc.
D-263-2013 - Non-Sterility
This Class I drug recall was voluntarily initiated by Hospira Inc. on October 5, 2012 for the product Drug. The FDA reported the reason for recall as non-sterility. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-263-2013
Non-Sterility: One confirmed customer report that product contained spore-like particulates, consistent with mold.
10-05-2012
04-24-2013
136,224 flexible containers
Recall Profile & Regulatory Data
Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Hospira Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Press Release
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide
08-21-2015
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Lactated Ringer's and 5% Dextrose Injection, USP, 1000 mL flexible containers, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7929-09.
Batch or Lot Expiration Information
Lot# :12-160-JT*, Exp 12/01/13; lot number * may be followed by 01 or 90